Information Collection; Commerce Patent Regulations, 56192-56193 [2019-22853]

Download as PDF 56192 Federal Register / Vol. 84, No. 203 / Monday, October 21, 2019 / Notices Total Annual Burden: 9,352 hours. Total Annual Cost: None. Obligation to Respond: Required to obtain or retain benefits. The statutory authority for this collection is contained in Sections 4(i), 4(j), 303(r), 339 and 340 of the Communications Act of 1934, as amended. Nature and Extent of Confidentiality: There is no need for confidentiality with this collection of information. Privacy Impact Assessment: No impact(s). Needs and Uses: The information collection requirements contained in 47 CFR 76.122, 76.123 and 76.124 are used to protect exclusive contract rights negotiated between broadcasters, distributors, and rights holders for the transmission of network syndicated in the broadcasters’ recognized market areas. Rule sections 76.122 and 76.123 implement statutory requirements to provide rights for in-market stations to assert non-duplication and exclusivity rights. Federal Communications Commission. Marlene Dortch, Secretary, Office of the Secretary. [FR Doc. 2019–22900 Filed 10–18–19; 8:45 am] BILLING CODE 6712–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meeting Thursday, October 24, 2019 at 10:00 a.m. TIME AND DATE: 1050 First Street NE, Washington, DC (12th Floor). PLACE: The October 24, 2019 Open Meeting has been canceled. STATUS: CONTACT PERSON FOR MORE INFORMATION: khammond on DSKJM1Z7X2PROD with NOTICES Judith Ingram, Press Officer, Telephone: (202) 694–1220. Individuals who plan to attend and require special assistance, such as sign language interpretation or other reasonable accommodations, should contact Laura E. Sinram, Acting Secretary and Clerk, at (202) 694–1040, at least 72 hours prior to the meeting date. Authority: Government in the Sunshine Act, 5 U.S.C. 552b. Laura E. Sinram, Acting Secretary and Clerk of the Commission. [FR Doc. 2019–22974 Filed 10–17–19; 11:15 am] BILLING CODE 6715–01–P VerDate Sep<11>2014 16:52 Oct 18, 2019 Jkt 250001 DEPARTMENT OF DEFENSE GENERAL SERVICES ADMINISTRATION NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [OMB Control No. 9000–0095; Docket No. 2019–0003; Sequence No. 31] Information Collection; Commerce Patent Regulations Department of Defense (DOD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA). ACTION: Notice and request for comments. AGENCY: In accordance with section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, and the Office of Management and Budget (OMB) regulations, DoD, GSA, and NASA invite the public to comment on a revision and renewal concerning Department of Commerce patent regulations. DoD, GSA, and NASA invite comments on: Whether the proposed collection of information is necessary for the proper performance of the functions of Federal Government acquisitions, including whether the information will have practical utility; the accuracy of the estimate of the burden of the proposed information collection; ways to enhance the quality, utility, and clarity of the information to be collected; and ways to minimize the burden of the information collection on respondents, including the use of automated collection techniques or other forms of information technology. OMB has approved this information collection for use through January 31, 2020. DoD, GSA, and NASA propose that OMB extend its approval for use for three additional years beyond the current expiration date. DATES: DoD, GSA, and NASA will consider all comments received by December 20, 2019. ADDRESSES: DoD, GSA, and NASA invite interested persons to submit comments on this collection by either of the following methods: • Federal eRulemaking Portal: This website provides the ability to type short comments directly into the comment field or attach a file for lengthier comments. Go to https:// www.regulations.gov and follow the instructions on the site. • Mail: General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW, Washington, DC 20405. ATTN: Lois SUMMARY: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Mandell/IC 9000–0095, Commerce Patent Regulations. Instructions: All items submitted must cite Information Collection 9000– 0095, Commerce Patent Regulations. Comments received generally will be posted without change to https:// www.regulations.gov, including any personal and/or business confidential information provided. To confirm receipt of your comment(s), please check www.regulations.gov, approximately two-to-three days after submission to verify posting (except allow 30 days for posting of comments submitted by mail). FOR FURTHER INFORMATION CONTACT: Zenaida Delgado, Procurement Analyst, at telephone 202–969–7207, or zenaida.delgado@gsa.gov. SUPPLEMENTARY INFORMATION: A. OMB Control Number, Title, and Any Associated Form(s) 9000–0095, Commerce Patent Regulations. B. Need and Uses The Federal Acquisition Regulation (FAR) subpart 27.3, Patents Rights under Government Contracts, implements the Department of Commerce regulation (37 CFR 401) based on chapter 18 of title 35 U.S.C., Presidential Memorandum on Government Patent Policy to the Heads of Executive Departments and Agencies, dated February 18, 1983, and Executive Order 12591, Facilitating Access to Science and Technology, dated April 10, 1987. Under the subpart, a contracting officer may insert the clause at FAR 52.227–11, Patent RightsOwnership by the Contractor, or 52.227–13, Patent Rights-Ownership by the Government, in solicitations and contracts pertaining to inventions made in the performance of experimental, developmental, or research work. In accordance with the clauses, a Government contractor must report all subject inventions to the contracting officer, submit a disclosure of the invention, and identify any publication, sale, or public use of the invention (FAR 52.227–11(c), 52.227–13(e)(1)). The contracting officer may modify FAR 52.227–11(e) or otherwise supplement the clause to require contractors to submit periodic or interim and final reports listing subject inventions (FAR 27.303(b)(2)(i) and (ii)). In order to ensure that subject inventions are reported, the contractor is required to establish and maintain effective procedures for identifying and disclosing subject inventions (FAR 52.227–11, Alternate IV; 52.227– E:\FR\FM\21OCN1.SGM 21OCN1 Federal Register / Vol. 84, No. 203 / Monday, October 21, 2019 / Notices 13(e)(1)). In addition, the contractor must require its employees, by written agreements, to disclose subject inventions (FAR 52.227–11(e)(2); 52.227–13(e)(4)). The contractor also has an obligation to utilize the subject invention, and agree to report, upon request, the utilization or efforts to utilize the subject invention (FAR 52.227–11(f); 52.227–13(c)(1)(iii)). C. Annual Burden Respondents: 3,379. Total Annual Responses: 13,200. Total Burden Hours: 52,800. Obtaining Copies: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW, Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 9000–0095, Commerce Patent Regulations, in all correspondence. Dated: October 16, 2019. Janet Fry, Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. [FR Doc. 2019–22853 Filed 10–18–19; 8:45 am] BILLING CODE 6820–EP–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3392–N] Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: This notice announces the request for nominations for membership on the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). Among other duties, the MEDCAC provides advice and guidance to the Secretary of the Department of Health and Human Services (the Secretary) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) concerning the adequacy of scientific evidence available to CMS in making coverage determinations under the Medicare program. The MEDCACs fundamental purpose is to support the principles of an khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:52 Oct 18, 2019 Jkt 250001 evidence-based determination process for Medicare’s coverage policies. MEDCAC panels provide advice to CMS on the strength of the evidence available for specific medical treatments and technologies through a public, participatory, and accountable process. DATES: Nominations must be received by Monday, November 18, 2019. ADDRESSES: You may mail nominations for membership to the following address: Centers for Medicare & Medicaid Services, Center for Clinical Standards and Quality, Attention: Leah Cromwell, 7500 Security Boulevard, Mail Stop: S3–02–01, Baltimore, MD 21244 or send via email to MEDCACnomination@cms.hhs.gov. FOR FURTHER INFORMATION CONTACT: Leah Cromwell, MEDCAC Coordinator, Centers for Medicare & Medicaid Services, Center for Clinical Standards and Quality, Coverage and Analysis Group, S3–02–01, 7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Cromwell by phone (410) 786–2243 or via email at Leah.Cromwell@cms.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background The Secretary signed the initial charter for the Medicare Coverage Advisory Committee (MCAC) on November 24, 1998. A notice in the Federal Register (63 FR 68780) announcing establishment of the MCAC was published on December 14, 1998. The MCAC name was updated to more accurately reflect the purpose of the committee and on January 26, 2007, the Secretary published a notice in the Federal Register (72 FR 3853), announcing that the Committee’s name changed to the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). The current Secretary’s Charter for the MEDCAC is available on the CMS website at: https:// www.cms.hhs.gov/FACA/Downloads/ medcaccharter.pdf, or you may obtain a copy of the charter by submitting a request to the contact listed in the FOR FURTHER INFORMATION section of this notice. The MEDCAC is governed by provisions of the Federal Advisory Committee Act, Public Law 92–463, as amended (5 U.S.C. App. 2), which sets forth standards for the formulation and use of advisory committees, and is authorized by section 222 of the Public Health Service Act as amended (42 U.S.C. 217A). We are requesting nominations for candidates to serve on the MEDCAC. Nominees are selected based upon their individual qualifications and not solely PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 56193 as representatives of professional associations or societies. We wish to ensure adequate representation of the interests of both women and men, members of all ethnic groups, and physically challenged individuals. Therefore, we encourage nominations of qualified candidates who can represent these interests. The MEDCAC consists of a pool of 100 appointed members including: 90 at-large standing members (10 of whom are patient advocates), and 10 representatives of industry interests. Members generally are recognized authorities in clinical medicine including subspecialties, administrative medicine, public health, biological and physical sciences, epidemiology and biostatistics, clinical trial design, health care data management and analysis, patient advocacy, health care economics, medical ethics or other relevant professions. The MEDCAC works from an agenda provided by the Designated Federal Official. The MEDCAC reviews and evaluates medical literature and technology assessments, and hears public testimony on the evidence available to address the impact of medical items and services on health outcomes of Medicare beneficiaries. The MEDCAC may also advise the Centers for Medicare & Medicaid Services (CMS) as part of Medicare’s ‘‘coverage with evidence development’’ initiative. II. Provisions of the Notice As of June 2020, there will be 25 membership terms expiring. Of the 25 memberships expiring, 2 are industry representatives, 5 are patient advocates and the remaining 18 membership openings are for the at-large standing MEDCAC membership. All nominations must be accompanied by curricula vitae. Nomination packages should be sent to Leah Cromwell at the address listed in the ADDRESSES section of this notice. Nominees are selected based upon their individual qualifications. Nominees for membership must have expertise and experience in one or more of the following fields: • Clinical medicine including subspecialties • Administrative medicine • Public health • Biological and physical sciences • Epidemiology and biostatistics • Clinical trial design • Health care data management and analysis • Patient advocacy • Health care economics • Medical ethics • Other relevant professions E:\FR\FM\21OCN1.SGM 21OCN1

Agencies

[Federal Register Volume 84, Number 203 (Monday, October 21, 2019)]
[Notices]
[Pages 56192-56193]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22853]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

GENERAL SERVICES ADMINISTRATION

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[OMB Control No. 9000-0095; Docket No. 2019-0003; Sequence No. 31]


Information Collection; Commerce Patent Regulations

AGENCY: Department of Defense (DOD), General Services Administration 
(GSA), and National Aeronautics and Space Administration (NASA).

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 3506(c)(2)(A) of the Paperwork 
Reduction Act of 1995, and the Office of Management and Budget (OMB) 
regulations, DoD, GSA, and NASA invite the public to comment on a 
revision and renewal concerning Department of Commerce patent 
regulations. DoD, GSA, and NASA invite comments on: Whether the 
proposed collection of information is necessary for the proper 
performance of the functions of Federal Government acquisitions, 
including whether the information will have practical utility; the 
accuracy of the estimate of the burden of the proposed information 
collection; ways to enhance the quality, utility, and clarity of the 
information to be collected; and ways to minimize the burden of the 
information collection on respondents, including the use of automated 
collection techniques or other forms of information technology. OMB has 
approved this information collection for use through January 31, 2020. 
DoD, GSA, and NASA propose that OMB extend its approval for use for 
three additional years beyond the current expiration date.

DATES: DoD, GSA, and NASA will consider all comments received by 
December 20, 2019.

ADDRESSES: DoD, GSA, and NASA invite interested persons to submit 
comments on this collection by either of the following methods:
     Federal eRulemaking Portal: This website provides the 
ability to type short comments directly into the comment field or 
attach a file for lengthier comments. Go to https://www.regulations.gov 
and follow the instructions on the site.
     Mail: General Services Administration, Regulatory 
Secretariat Division (MVCB), 1800 F Street NW, Washington, DC 20405. 
ATTN: Lois Mandell/IC 9000-0095, Commerce Patent Regulations.
    Instructions: All items submitted must cite Information Collection 
9000-0095, Commerce Patent Regulations. Comments received generally 
will be posted without change to https://www.regulations.gov, including 
any personal and/or business confidential information provided. To 
confirm receipt of your comment(s), please check www.regulations.gov, 
approximately two-to-three days after submission to verify posting 
(except allow 30 days for posting of comments submitted by mail).

FOR FURTHER INFORMATION CONTACT: Zenaida Delgado, Procurement Analyst, 
at telephone 202-969-7207, or [email protected].

SUPPLEMENTARY INFORMATION:

A. OMB Control Number, Title, and Any Associated Form(s)

    9000-0095, Commerce Patent Regulations.

B. Need and Uses

    The Federal Acquisition Regulation (FAR) subpart 27.3, Patents 
Rights under Government Contracts, implements the Department of 
Commerce regulation (37 CFR 401) based on chapter 18 of title 35 
U.S.C., Presidential Memorandum on Government Patent Policy to the 
Heads of Executive Departments and Agencies, dated February 18, 1983, 
and Executive Order 12591, Facilitating Access to Science and 
Technology, dated April 10, 1987. Under the subpart, a contracting 
officer may insert the clause at FAR 52.227-11, Patent Rights-Ownership 
by the Contractor, or 52.227-13, Patent Rights-Ownership by the 
Government, in solicitations and contracts pertaining to inventions 
made in the performance of experimental, developmental, or research 
work.
    In accordance with the clauses, a Government contractor must report 
all subject inventions to the contracting officer, submit a disclosure 
of the invention, and identify any publication, sale, or public use of 
the invention (FAR 52.227-11(c), 52.227-13(e)(1)). The contracting 
officer may modify FAR 52.227-11(e) or otherwise supplement the clause 
to require contractors to submit periodic or interim and final reports 
listing subject inventions (FAR 27.303(b)(2)(i) and (ii)). In order to 
ensure that subject inventions are reported, the contractor is required 
to establish and maintain effective procedures for identifying and 
disclosing subject inventions (FAR 52.227-11, Alternate IV; 52.227-

[[Page 56193]]

13(e)(1)). In addition, the contractor must require its employees, by 
written agreements, to disclose subject inventions (FAR 52.227-
11(e)(2); 52.227-13(e)(4)). The contractor also has an obligation to 
utilize the subject invention, and agree to report, upon request, the 
utilization or efforts to utilize the subject invention (FAR 52.227-
11(f); 52.227-13(c)(1)(iii)).

C. Annual Burden

    Respondents: 3,379.
    Total Annual Responses: 13,200.
    Total Burden Hours: 52,800.
    Obtaining Copies: Requesters may obtain a copy of the information 
collection documents from the General Services Administration, 
Regulatory Secretariat Division (MVCB), 1800 F Street NW, Washington, 
DC 20405, telephone 202-501-4755. Please cite OMB Control No. 9000-
0095, Commerce Patent Regulations, in all correspondence.

    Dated: October 16, 2019.
Janet Fry,
Director, Federal Acquisition Policy Division, Office of Governmentwide 
Acquisition Policy, Office of Acquisition Policy, Office of 
Governmentwide Policy.
[FR Doc. 2019-22853 Filed 10-18-19; 8:45 am]
BILLING CODE 6820-EP-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.